— Know what they know.
Not Investment Advice

RGNX NASDAQ

REGENXBIO Inc.
1W: +8.2% 1M: -27.7% 3M: -17.1% YTD: -50.3% 1Y: -32.5% 3Y: -65.8% 5Y: -81.3%
$6.35
-0.40 (-5.93%)
 
Weekly Expected Move ±21.1%
$3 $5 $6 $7 $8
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 25 · $328.3M mcap · 43M float · 2.57% daily turnover · Short 60% of daily vol

Balance Sheet Trends

Total Assets
$453M -2.8% ▼
5Y CAGR: -8.5%
Total Liabilities
$350M +69.8% ▲
5Y CAGR: +1.2%
Shareholders Equity
$103M -60.4% ▼
5Y CAGR: -22.9%
Cash & Investments
$230M -2.0% ▼
5Y CAGR: -13.5%
Total Debt
$261M +217.6% ▲
5Y CAGR: +29.1%
Net Debt
$226M +822.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$345M$97M$35M$58M$34M
Short-Term Investments$112M$268M$241M$177M$196M
Cash & ST Investments$457M$365M$275M$235M$230M
Net Receivables$32M$30M$26M$22M$26M
Inventory$0$0$0$0$0
Other Current Assets$10M$7M$19M$13M$25M
Total Current Assets$519M$416M$335M$278M$281M
Property, Plant & Equip.$192M$207M$193M$171M$152M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$392M$201M$39M$10M$15M
Other Non-Current Assets$11M$10M$8M$7M$5M
Total Non-Current Assets$595M$417M$239M$188M$172M
Total Assets$1.1B$833M$574M$466M$453M
— Liabilities —
Accounts Payable$11M$27M$23M$23M$21M
Short-Term Debt$0$0$0$0$48M
Deferred Revenue$3M$2M$148K$115K$10M
Other Current Liabilities$58M$67M$86M$52M$38M
Total Current Liabilities$130M$130M$130M$103M$118M
Long-Term Debt$0$0$0$0$147M
Other Non-Current Liab.$134M$98M$50M$29M$638K
Total Non-Current Liabilities$219M$187M$132M$103M$232M
Total Liabilities$350M$317M$262M$206M$350M
— Equity —
Common Stock$4K$4K$4K$5K$5K
Retained Earnings-$161M-$442M-$705M-$932M-$1.1B
Accumulated OCI-$3M-$15M-$4M-$741K-$687K
Total Stockholders Equity$764M$516M$312M$260M$103M
Total Liabilities & Equity$1.1B$833M$574M$466M$453M
— Key Metrics —
Total Debt$87M$95M$89M$82M$261M
Net Debt-$259M-$2M$55M$25M$226M
Total Investments$504M$468M$280M$187M$211M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms